Cabot Corporation Common Stock (CBT) stock analysis
CBT · Cabot Corporation Common Stock
Latest recorded price: USD 70.94
Model-estimated fair value: USD 75.79. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Basic Materials · Specialty Chemicals
At $70.94, CBT trades 6.4% below the model's base-case value of $75.79. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $55.80 in the conservative case and $97.96 in the optimistic case, with a valuation confidence score of 83/100. About 73% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -4.9%, free cash flow margin 10.5%, ROIC 18.9%. The model flags 2 risk signals for this company (1 high severity).